Though we acknowledge that not every care decision is controlled by the attributed participant by including services initiated by other clinicians, the measure appropriately incentivizes specialists to coordinate care and manage transitions to reduce avoidable, duplicative, fragmented and costly services
Do not self-adjust or discontinue injections without consulting your provider
When combined with your biomarkers and medical history, this context can support a more personalized provider conversation about formulation selection and realistic outcome expectations
If treatment intensification is required to improve glycemic control, oral medications (e.g., SGLT2is, DPP-4 inhibitors, sulfonylureas, or thiazolidinediones) and injectables (GLP-1RAs and insulins) can be considered, with many options for combining these therapies to step up treatment as needed to improve glycemic control [15, 17]
Most clients experience no downtime, such as swelling, bruising, or lumps, making it a convenient and comfortable treatment option
